Bank of New Hampshire decreased its holdings in Oracle Co. (NYSE:ORCL – Free Report) by 1.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 21,461 shares of the enterprise software provider’s stock after selling 374 shares during the quarter. Bank of New Hampshire’s holdings in Oracle were worth $3,576,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Fairway Wealth LLC acquired a new stake in Oracle during the 2nd quarter worth about $27,000. Quest Partners LLC bought a new position in Oracle in the 2nd quarter worth $40,000. Reston Wealth Management LLC acquired a new position in shares of Oracle during the third quarter worth approximately $44,000. Avondale Wealth Management bought a new stake in shares of Oracle in the third quarter valued at about $51,000. Finally, Friedenthal Financial acquired a new position in shares of Oracle in the third quarter valued at $51,000. Institutional investors own 42.44% of the company’s stock.
Oracle Stock Down 1.0 %
Oracle stock traded down $1.59 during trading hours on Tuesday, hitting $164.10. 536,965 shares of the stock traded hands, compared to its average volume of 4,617,722. Oracle Co. has a one year low of $102.13 and a one year high of $198.31. The company has a current ratio of 0.81, a quick ratio of 0.72 and a debt-to-equity ratio of 5.65. The company has a market cap of $458.98 billion, a PE ratio of 40.12, a PEG ratio of 3.39 and a beta of 1.06. The firm’s 50-day moving average price is $178.48 and its two-hundred day moving average price is $160.45.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.40 per share. The ex-dividend date is Friday, January 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.98%. Oracle’s payout ratio is 39.12%.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. Oppenheimer reiterated a “market perform” rating on shares of Oracle in a research note on Tuesday, September 10th. Monness Crespi & Hardt downgraded shares of Oracle from a “neutral” rating to a “sell” rating and set a $130.00 price target on the stock. in a research report on Friday, December 20th. Melius raised Oracle from a “hold” rating to a “buy” rating and set a $210.00 price objective on the stock in a report on Monday, September 16th. Citigroup upped their target price on shares of Oracle from $157.00 to $194.00 and gave the company a “neutral” rating in a research report on Tuesday, December 10th. Finally, BMO Capital Markets lifted their price objective on Oracle from $173.00 to $205.00 and gave the stock a “market perform” rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $181.48.
Read Our Latest Analysis on Oracle
Oracle Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also
- Five stocks we like better than Oracle
- Options Trading – Understanding Strike Price
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
- How Can Investors Benefit From After-Hours Trading
- NVIDIA Is Still the Most Important Stock in the Market
- Why Are These Companies Considered Blue Chips?
- 2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.